Stay updated on Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial

Sign up to get notified when there's something new on the Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T23:49:31.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the efficacy, safety, and tolerability comparison between upadacitinib and placebo for the treatment of signs and symptoms of subjects with moderately to severely active rheumatoid arthritis.
    Difference
    0.1%
    Check dated 2024-06-06T14:45:50.000Z thumbnail image
  7. Check
    26 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study, specifying the diagnosis requirements and prior treatments for participants with rheumatoid arthritis. Previously, this section had no information provided.
    Difference
    19%
    Check dated 2024-05-22T21:30:59.000Z thumbnail image
  8. Check
    48 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:01:30.000Z thumbnail image

Stay in the know with updates to Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial page.